Not just wear-and-tear: what post-traumatic knee OA is

Persistent knee pain that lingers months or years after a sporting injury is not simply bad luck, and it is not the same as the joint wear that comes with getting older. What many people in this situation have is post-traumatic osteoarthritis (PTOA) — a distinct form of OA that develops as a direct consequence of earlier joint damage, rather than as a gradual effect of age alone.

Age-related OA unfolds slowly over decades, shaped by accumulated loading and biological ageing. After a significant knee injury — an ACL tear, a meniscus rupture, or a combination of both — the joint can begin deteriorating far sooner, sometimes within a decade of the original trauma. Sports activities that involve rapid pivots, sudden stops, or directional changes, such as football, skiing, and basketball, are among the most common contexts for the kind of knee injury that starts this chain of events.

PTOA has its own epidemiology and biological pathway. Recognising it as a separate clinical entity — not simply early-onset wear-and-tear — is important because the trajectory, the timescale, and the options for slowing or managing its progression are meaningfully different from those for age-related OA. If you had a significant knee injury years ago and are now noticing pain, stiffness, or reduced movement, understanding which of these two processes is at work is the first step toward choosing the right response.

Which sports injuries carry the highest risk

Not all knee injuries carry equal risk of long-term joint damage. The ACL tear stands out as the sporting injury most strongly associated with PTOA, but the decisive factor is rarely the ligament alone.

Population studies suggest that only around 20% of ACL tears are isolated injuries. In approximately half of all cases, the cartilage, meniscus, or collateral ligaments are also damaged at the moment of impact. That distinction drives a striking difference in long-term outcomes: OA prevalence of 0–13% is reported following an isolated ACL injury at follow-up, rising to 21–48% when the ACL tear is accompanied by concurrent meniscal damage. This dose-response pattern — more structures damaged at the time of injury, substantially higher OA risk in the years that follow — explains why two people with apparently similar knee injuries can follow very different long-term trajectories. It is the total burden of structural damage sustained in a single incident, not the ACL tear in isolation, that is the stronger predictor of what the joint looks like a decade on.

The sports most likely to produce these combined injury patterns are those demanding rapid deceleration, pivoting under load, and sudden directional changes. Football, skiing, and basketball generate precisely the knee-loading conditions in which simultaneous ligament, meniscal, and cartilage injury becomes more probable within a single incident.

As a load-distributing, shock-absorbing wedge between femur and tibia, the meniscus plays a protective role that becomes especially consequential after ACL disruption. When it is torn alongside the ligament — a common finding rather than an exceptional one — the joint loses two stabilising structures simultaneously, compounding the biological response described in the following section.

How a single impact sets off years of joint change

The joint's response to trauma begins before any inflammation is visible. At the moment of impact, the bone beneath the cartilage absorbs compressive force and develops bone marrow lesions (BMLs) — areas of localised bone stress that show up on MRI and are now recognised as potential early markers of post-traumatic OA.

Within weeks, the joint begins to move differently. Studies using T2-weighted MRI — a technique sensitive to changes in cartilage collagen structure and water content — show measurable loading alterations as early as one month after an ACL injury. Changes in how load is distributed sideways across the knee, and a reduction in how far the knee bends during walking, account for a substantial portion of early cartilage signal change. The joint redistributes load across tissue that is now slightly compromised, and that redistribution carries consequences that compound over time.

Simultaneously, an inflammatory cascade sets in. Cytokines including interleukin-1β (IL-1β), interleukin-6, and tumour necrosis factor-α (TNF-α) rise in proportion to injury severity and can persist well beyond the acute phase, sustaining cartilage breakdown over months and years rather than resolving with the swelling.

At the cellular level, two further processes compound the damage. Chondrocytes — the cells responsible for maintaining cartilage — undergo accelerated ageing (senescence), gradually losing their capacity to repair the tissue. Abnormal mechanical loading also generates oxidative stress within chondrocyte mitochondria, causing further cellular injury. Together, these mechanisms produce cartilage loss that accumulates quietly and is difficult to reverse.

Surgical reconstruction improves mechanical stability but does not fully switch off the biological cascade. Evidence suggests that operating on an injured joint can itself provoke a secondary biological response, adding to the process already underway rather than replacing it. Stability and biology are connected, but they are not the same problem.

Researchers are investigating molecular targets within this cascade — including a protein called LOXL2, whose reduced activity in PTOA cartilage appears to worsen inflammation and structural breakdown. This remains an area of active laboratory research, not yet a clinical option, but it reflects a broader scientific effort to intercept the cascade at its source.

Why meniscal damage changes the prognosis

Evidence from the Framingham Study, led by Englund et al, offers a reframing that matters clinically: meniscal damage is not simply a co-injury that raises OA risk — it appears to be an integral component of the osteoarthritis process itself, rather than a separate, preceding event. That distinction changes how combined ACL-and-meniscus injuries should be understood. The meniscal tear is not merely a compounding factor; in many cases it may be inseparable from the OA trajectory that follows.

The mechanism is mechanical. An intact meniscus distributes contact forces broadly across the tibial plateau; when it is torn or dysfunctional, that load concentrates onto a smaller area of articular cartilage. Those high-pressure zones are then subject to the same chronic mechanical insult — at the cellular level — that drives chondrocyte senescence and oxidative damage. Surgical reconstruction of the ACL restores ligamentous stability but cannot restore normal meniscal anatomy if the meniscal tissue itself has been lost or structurally altered. The two problems require separate consideration, and resolving one does not automatically resolve the other.

The practical implication is straightforward. Anyone whose original knee injury involved both the ACL and the meniscus is not in the average-risk ACL group — they are in the group where OA development is more probable and, in some cases, faster in onset. Knowing this is useful not as a verdict but as a monitoring guide: it shapes how frequently reassessment is warranted and what symptoms — new swelling, a change in mechanical symptoms, or a shift in pain pattern — should prompt an earlier appointment rather than a wait-and-see approach.

What PTOA looks like 10–15 years on

The longer-term picture that the Lohmander cohort established — radiographic OA, persistent pain, and measurable functional loss at 12-year follow-up — is not a worst-case outlier for a minority. Evidence from reconstruction cohorts shows it describes a common trajectory, and that radiographic OA is directly associated with reduced knee symptoms, diminished function, and lower quality of life at the 10–15-year mark, even in people who underwent surgery and completed rehabilitation.

What changes over that period is not just the imaging. The practical consequences accumulate: reduced pain-free range of movement, difficulty sustaining the loading demands of sport at previous intensity, and a shift in what the knee will tolerate from one day to the next. These findings align with what many patients describe — a joint that manages daily life adequately but no longer performs at its former level.

Many people at this stage reach what clinicians sometimes call a therapeutic gap. The joint has deteriorated beyond the point where focal cartilage repair techniques are most useful — those work best on contained, well-defined defects in a mechanically stable knee — yet it is not at the threshold where joint replacement becomes appropriate. Managing this middle phase is not passive. It typically involves structured load management, weight optimisation, targeted physiotherapy to reduce compressive forces at the joint, and injection therapies aimed at symptom support and slowing progression. The decisions here are real and consequential, not simply a holding pattern.

The PRRR framework — Preserve, Repair, Regenerate, Replace — reflects how clinicians think across this staged trajectory. Preservation and load reduction come first; biological and regenerative approaches occupy the middle ground; replacement follows when earlier strategies are no longer sufficient.

How quickly any individual moves through this trajectory depends heavily on how much structural damage occurred at the original injury, age at the time, and how joint loading has been managed in the years since.

When and how to get reassessed

Recognising when a previously injured knee has changed is the first practical step. New or worsening pain, stiffness that persists after rest, a reduction in range of movement, or episodes of swelling — particularly in a knee with a documented injury history — are not symptoms to manage alone indefinitely. They are reasonable grounds for a reassessment, even if the original injury was treated years ago.

Specialist assessment at this stage typically draws on three sources: a detailed clinical history (including how symptoms have evolved since the original injury), physical examination of joint mechanics and stability, and targeted imaging. The important principle is that imaging and symptoms are interpreted together, not in isolation. A scan showing cartilage changes in someone with no functional limitation calls for a different response than the same finding in someone whose daily activity has declined noticeably; the image alone is not a verdict.

For most people in the early stages of PTOA, conservative care remains the appropriate first response — structured physiotherapy, activity modification, and graduated load management. These approaches do not reverse established joint change, but evidence supports their role in managing symptoms and reducing the mechanical stress that drives further deterioration.

When conservative care plateaus and symptoms continue to restrict daily life or activity, biological and injection-based therapies may be appropriate for the middle phase of the pathway. What is suitable depends on the individual's stage of joint degeneration, symptom profile, and treatment history — a specialist review is the appropriate route to that determination.

Surgical options, from joint-preservation procedures through to replacement, are assessed on an individual basis and represent a downstream decision rather than an automatic next step when other measures have not brought sufficient relief.

1. [1] Post-traumatic arthritis. https://en.wikipedia.org/?curid=56957582 https://en.wikipedia.org/?curid=56957582
2. [2] Anterior cruciate ligament injury. https://en.wikipedia.org/?curid=5811552 https://en.wikipedia.org/?curid=5811552
3. [3] Deep learning-based automated detection and segmentation of bone and traumatic bone marrow lesions from MRI following an acute ACL tear. (2024). https://doi.org/10.1016/j.compbiomed.2024.108791 https://doi.org/10.1016/j.compbiomed.2024.108791
4. [4] LOXL2 alleviates post-traumatic knee osteoarthritis and pain. (2025). https://doi.org/10.1016/j.jot.2025.08.016 https://doi.org/10.1016/j.jot.2025.08.016
5. [5] Navigating Post-operative Challenges: Complications Following ACL Tear Surgery. (2024). https://doi.org/10.7759/cureus.67768 https://doi.org/10.7759/cureus.67768
6. [6] Knee joint unloading and daily physical activity associate with cartilage T2 relaxation times 1 month after ACL injury. (2021). https://doi.org/10.1002/jor.25034 https://doi.org/10.1002/jor.25034
7. [7] Elevated levels of IL-1β, IL-6, TNF-α and VEGF in patients with knee articular cartilage injury. (2019). https://doi.org/10.12998/wjcc.v7.i11.1262 https://doi.org/10.12998/wjcc.v7.i11.1262